| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4170863 | Paediatric Respiratory Reviews | 2010 | 7 Pages |
Abstract
SummaryInterest in azithromycin in the management of patients with cystic fibrosis has grown over the last decade. Uniquely this drug has both antibacterial and immune modulating effects which appear to be the reason for its clinical benefit as proven in several well designed clinical studies. In this review we discuss the proposed mechanisms of action of azithromycin and review the evidence for its clinical effectiveness and safety in cystic fibrosis.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Abdullah A. Yousef, Adam Jaffe,